These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34344226)

  • 1. Acute Demyelinating Syndrome (MOG Antibody Positive) Associated With COVID-19 Infection: A Widening spectrum.
    Sinha R; Wander A; Kapoor A; Yadav R; Kumar A; Gulati S
    Clin Pediatr (Phila); 2021 Nov; 60(13):501-503. PubMed ID: 34344226
    [No Abstract]   [Full Text] [Related]  

  • 2. Myelin Oligodendrocyte Glycoprotein-Associated Pediatric Central Nervous System Demyelination: Clinical Course, Neuroimaging Findings, and Response to Therapy.
    Thulasirajah S; Pohl D; Davila-Acosta J; Venkateswaran S
    Neuropediatrics; 2016 Aug; 47(4):245-52. PubMed ID: 27128728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in a COVID-19 patient: A case report.
    Kogure C; Kikushima W; Fukuda Y; Hasebe Y; Takahashi T; Shibuya T; Sakurada Y; Kashiwagi K
    Medicine (Baltimore); 2021 May; 100(19):e25865. PubMed ID: 34106635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI features of demyelinating disease associated with anti-MOG antibodies in adults.
    Denève M; Biotti D; Patsoura S; Ferrier M; Meluchova Z; Mahieu L; Heran F; Vignal C; Deschamps R; Gout O; Champfleur NM; Ayrignac X; Dallière CC; Labauge P; Dulau C; Tourdias T; Dumas H; Cognard C; Brassat D; Bonneville F
    J Neuroradiol; 2019 Sep; 46(5):312-318. PubMed ID: 31228536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical spectrum, treatment and outcome of myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease in children: a tertiary care experience.
    Serin HM; Yilmaz S; Simsek E; Kanmaz S; Eraslan C; Aktan G; Tekgul H; Gokben S
    Acta Neurol Belg; 2021 Feb; 121(1):231-239. PubMed ID: 33231843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19-Induced Acute Bilateral Optic Neuritis.
    Sawalha K; Adeodokun S; Kamoga GR
    J Investig Med High Impact Case Rep; 2020; 8():2324709620976018. PubMed ID: 33238757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiological characteristics of myelin oligodendrocyte glycoprotein antibody disease.
    Salama S; Khan M; Levy M; Izbudak I
    Mult Scler Relat Disord; 2019 Apr; 29():15-22. PubMed ID: 30658259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2-related Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease: A Case Report and Literature Review.
    Ide T; Kawanami T; Eriguchi M; Hara H
    Intern Med; 2022 Apr; 61(8):1253-1258. PubMed ID: 35135920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute inflammatory demyelinating optic neuritis: current concepts in diagnosis and management.
    Bhatti MT; Schmitt NJ; Beatty RL
    Optometry; 2005 Sep; 76(9):526-35. PubMed ID: 16198993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI of the first event in pediatric acquired demyelinating syndromes with antibodies to myelin oligodendrocyte glycoprotein.
    Baumann M; Grams A; Djurdjevic T; Wendel EM; Lechner C; Behring B; Blaschek A; Diepold K; Eisenkölbl A; Fluss J; Karenfort M; Koch J; Konuşkan B; Leiz S; Merkenschlager A; Pohl D; Schimmel M; Thiels C; Kornek B; Schanda K; Reindl M; Rostásy K
    J Neurol; 2018 Apr; 265(4):845-855. PubMed ID: 29423614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postinfectious Encephalomyelitis Associated With Myelin Oligodendrocyte Glycoprotein Antibody in a Pediatric Patient With COVID-19.
    Cay-Martínez KC; Shen MY; Silver WG; Vargas WS
    Pediatr Neurol; 2021 Nov; 124():40-41. PubMed ID: 34509727
    [No Abstract]   [Full Text] [Related]  

  • 12. Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Disease in a 11 Year Old with COVID-19 Infection.
    Khan A; Panwala H; Ramadoss D; Khubchandani R
    Indian J Pediatr; 2021 May; 88(5):488-489. PubMed ID: 33471314
    [No Abstract]   [Full Text] [Related]  

  • 13. Myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies are highly specific in children with acquired demyelinating syndromes.
    Duignan S; Wright S; Rossor T; Cazabon J; Gilmour K; Ciccarelli O; Wassmer E; Lim M; Hemingway C; Hacohen Y
    Dev Med Child Neurol; 2018 Sep; 60(9):958-962. PubMed ID: 29468668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis.
    Bensi C; Marrodan M; González A; Chertcoff A; Osa Sanz E; Chaves H; Schteinschnaider A; Correale J; Farez MF
    Mult Scler Relat Disord; 2018 Oct; 25():246-250. PubMed ID: 30144694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical spectrum of inflammatory central nervous system demyelinating disorders associated with antibodies against myelin oligodendrocyte glycoprotein.
    Akaishi T; Sato DK; Takahashi T; Nakashima I
    Neurochem Int; 2019 Nov; 130():104319. PubMed ID: 30365980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study.
    Mariotto S; Ferrari S; Monaco S; Benedetti MD; Schanda K; Alberti D; Farinazzo A; Capra R; Mancinelli C; De Rossi N; Bombardi R; Zuliani L; Zoccarato M; Tanel R; Bonora A; Turatti M; Calabrese M; Polo A; Pavone A; Grazian L; Sechi G; Sechi E; Urso D; Delogu R; Janes F; Deotto L; Cadaldini M; Bianchi MR; Cantalupo G; Reindl M; Gajofatto A
    J Neurol; 2017 Dec; 264(12):2420-2430. PubMed ID: 29063242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overlapping autoimmune syndrome: A case of concomitant anti-NMDAR encephalitis and myelin oligodendrocyte glycoprotein (MOG) antibody disease.
    Pérez CA; Agyei P; Gogia B; Harrison R; Samudralwar R
    J Neuroimmunol; 2020 Feb; 339():577124. PubMed ID: 31837635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelin Oligodendrocyte Glycoprotein Antibody Persistency in a Steroid-Dependent ADEM Case.
    Polat İ; Yiş U; Karaoğlu P; Ayanoğlu M; Öztürk T; Güleryüz H; Kurul SH
    Pediatrics; 2016 May; 137(5):. PubMed ID: 27244783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features of demyelinating optic neuritis with seropositive myelin oligodendrocyte glycoprotein antibody in Chinese patients.
    Zhao Y; Tan S; Chan TCY; Xu Q; Zhao J; Teng D; Fu H; Wei S
    Br J Ophthalmol; 2018 Oct; 102(10):1372-1377. PubMed ID: 29363529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis and Myelitis in COVID-19.
    Zhou S; Jones-Lopez EC; Soneji DJ; Azevedo CJ; Patel VR
    J Neuroophthalmol; 2020 Sep; 40(3):398-402. PubMed ID: 32604245
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.